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Summary
Randall’s plaques are very common in idiopathic calcium-ox-
alate nephrolithiasis. These papillary plaques have an apatite
mineral structure. While these calcium deposits are generally
assumed to be secondary to a purely physico-chemical phe-
nomenon, we advance the hypothesis that they form due to a
truly ectopic biomineralization in the renal tissue, and that
Henle’s loop epithelial cells, or pericyte-like interstitial cells,
or papillary stem cells differentiating along a bone lineage
might be involved.
KEY WORDS: CaOx renal stones, ectopic calcification, epithelial-mesenchy-
mal transformation, papilla, Randall’s plaque.
Calcium nephrolithiasis: a puzzling pathogenesis
In 1937 Randall (1) described calcium-phosphate plaques in
stone formers, i.e. sites of interstitial crystal deposition at or
near the tip of the papilla, that he conjectured might trigger cal-
cium-oxalate (CaOx) stone formation at these sites (1). His
findings were confirmed by others (2-5), but until the recent pa-
per by Evan et al. in Indianapolis (6) this discovery was not ad-
equately recognized as an important step forward in our under-
standing of the pathogenesis of renal stones. Over the last 3
decades, the putative pathogenic framework of renal stones
has included a number of other hypotheses, ideas and obser-
vations, leaving the role of Randall’s plaque in the background.
Briefly, major breakthroughs have been:
1. the hypothesis of a physico-chemical imbalance in pre-urine
somewhere in the nephron to explain crystallization; 
2. the fixed particle theory, i.e. the attachment of CaOx crystals
to the tubular epithelium to explain how crystals can become
large enough to become trapped in the tubular lumen, thus en-
abling their evolution into stones;
3. the role of defective renal tubular cells in determining the
pre-urine physico-chemical imbalance and/or the deposition of
crystals on them;
4. the discovery of a number of crystal growth and aggregation
inhibitors, including macromolecules such as bikunin, nephro-
calcin and osteopontin.
Like the Phoenix, however, Randall’s plaque has very recently
been reborn. Evan et al. (6) have shown that it probably origi-
nates in the basement membranes of the thin loops of Henle
and spreads from there through the interstitium to underneath
the papillary urothelium; the same group has presented data
supporting Randall’s idea that CaOx stones form on the plaque
in the renal pelvis (2, 3, 7).
But we still have to discover how these pieces of the puzzle fit
together. We do not know whether (or where) crystals indeed
form in the nephron lumen; nor do we know the fate of these
putative intraluminal fixed crystals. As a matter of fact, the Indi-
anapolis group found no crystals in Henle’s loop, close to the
supposedly germinating plaques (6), at the only site in the
nephron where spontaneous calcium phosphate crystallization
could occur (8). Moreover, the thin Henle’s loop epithelia lying
over the basement membrane concretions looks normal, with
no signs of damage or crystals inside. So how do these base-
ment membrane concretions form in the Henle’s forceps? 
Calcium phosphate crystals have oddly only been observed in
Bellini’s ducts in intestinal hyperoxaluric CaOx stone formers,
attached to a distorted epithelium (6), close to the papillary tip,
suggesting that once heterogeneous crystallization has led to
the formation of a CaOx stone, this stone can easily extrude in-
to the renal pelvis. This is a very different picture, however,
from the situation seen in idiopathic CaOx stone formers,
where there are no concretions on the overlying “mineralized”
basement membrane (6).
In short, therefore, we are unable to combine the physico-
chemical and fixed-particle theories of stone formation with the
discovery of basement membrane and interstitial calcifications
in the papilla (5, 6), with the hypothesis that Randall’s plaque
forms from these concretions, and finally with the very strong
evidence that CaOx stones form and grow on Randall’s plaque
in the renal pelvis (1, 3, 7, 9). 
Perhaps we should admit that the influence of intraluminal
events in the nephron on the pathogenesis of idiopathic calci-
um renal stones has been overestimated. We guess that it is
time to piece together many recent findings reported by differ-
ent “renal stone investigators” following up very different hy-
potheses, and to interpret them also in the light of intriguing
findings emerging in quite different areas of research concern-
ing bone and vascular biology (10).
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Does biomineralization have a role in nephrolithiasis?
In the last decade, some very distinguished investigators have
attempted to identify the effects of high oxalate and crystal con-
centrations on the biology of renal tubular cells. In in vitro mod-
els, oxalate has been shown to trigger inflammatory, oxidative,
chemotactic, and fibrogenic loops (11-13). Generally speaking,
very high oxalate concentrations were used in these studies,
though this makes them more relevant to primary hyperoxaluria
than to idiopathic CaOx renal stones. In addition, the possibility
that these conditions may trigger the transdifferentiation of
tubular cells was not investigated. It would be very interesting
and relevant to the present hypothesis to explore whether culti-
vated renal tubular cells – the origin of which is mesodermal,
despite their epithelial appearance – may be induced to under-
go epithelial-mesenchymal transdifferentiation under the influ-
ence of the paraphysiological oxalate concentrations observed
in idiopathic CaOx stone formers. This may be the case, since
these epithelial cells have the genetic program of cells of mes-
enchymal origin.
As a matter of fact, Myazawa et al. (14, and personal commu-
nication) have demonstrated that CaOx crystals upregulate the
gene transcription for vimentin (an embryonic marker of the
multipotent kidney mesenchyme) in normal rat kidney proximal
cells. 
The phenomenon of tubular epithelial cell differentiation into
cells with the mesenchymal phenotype is well known. Studies
suggest that renal interstitial myofibroblasts originate from re-
nal tubular cells undergoing epithelial-mesenchymal transfor-
mation (15). The phenomenon of differentiation is restricted
neither to the kidney, nor to the epithelial cell, since it also oc-
curs in liver Ito cells (16) and in a subpopulation of smooth
muscle cells in the intima of arteries. Both these cell popula-
tions are thought to be pericyte-like cells. Notably, vascular
pericytes have the ability to undergo osteoblastic differentiation
and mineralization (17, 18) and seem to play a crucial part in
ectopic vascular calcification. Long thought due to passive de-
generation, vascular calcification instead derives from a com-
plex and strictly-regulated process of biomineralization resem-
bling osteogenesis (19). There is evidence to indicate that pro-
teins controlling bone mineralization are also involved in regu-
lating vascular calcification. Cultured artery smooth muscle
cells are also induced to become osteogenic by inflammatory
stimuli, reactive oxygen species and hypoxia (20). 
A similar phenomenon may occur in the renal papilla, where
CaOx crystals and/or oxalate at paraphysiologically high con-
centrations or, more likely, a high pre-urine CaOx supersatura-
tion in conjunction with an unfavorably low oxygen tension may
trigger inflammation in cells at the bend of the long loop of
Henle. This would make these cells transdifferentiate towards
the osteogenic lineage, causing the synthesis of typical bone
osteoid proteins (osteopontin, osteocalcin, BMP-2, etc.) and a
true biological hydroxyapatite mineralization of the Henle’s loop
basement membrane (beneath the differentiating cells). While
both hydroxyapatite and brushite have been identified in
stones, depending on the clinical phenotype (21), any exis-
tence of brushite in calcified tissue has been ruled out (22). Re-
ports that Randall’s plaque and the preceding crystalline struc-
tures in the basement membrane and papillary interstitium are
composed of bone-like hydroxyapatite crystals (6,23) thus sup-
port the hypothesis that they are the consequence of an active
process of biomineralization, and therefore that the Henle’s
loop cells are capable of differentiation.
Concerning the active process of biomineralization, it is worth
noting that osteopontin has been found localized in the Golgi
apparatus precisely of thin loop of Henle cells in the normal rat
kidney (24). Osteopontin was detected in the lamellae and stri-
ations of the organic matrix in human calcium oxalate monohy-
drate stones (25); this observation and in vitro findings have
led to the suggestion that osteopontin is a powerful inhibitor of
CaOx crystallization (26), which may actually be the case,
though we speculate that it might also well reflect the biominer-
alization process occurring at the tip of Henle’s loop and in the
papillae. 
Although almost all in vitro studies on epithelial mesenchymal
differentiation and oxalate toxicity used proximal tubular cells
as a model, it would be hardly surprising to find that Henle’s
cells also undergo differentiation after injury. For the purposes
of our hypothesis, however, more interest lies in the findings
recently reported by Kumar et al. (27) that inner medullary col-
lecting duct cells grown in a calcifying media tend to form cal-
cific nodules that are positive for typical bone proteins, osteo-
pontin and bone sialoprotein. This is specifically realistic con-
sidering that proximal and collecting tubule epithelia and Hen-
le’s tubules have the same embryonic, mesenchymal origin. 
Multipotent interstitial cells may also have a role
An alternative possibility is that the interstitial renal cells (peri-
cyte-like cells) thought to be involved in the process of fibroge-
nesis because of their differentiation into myofibroblasts (15,
28, 29) may also differentiate into the bone lineage when ex-
posed to the inflammatory environment created by oxalate on
the neighboring Henle cells: a cross-talk between these two
cells has been postulated (30). In the same way as for calcify-
ing vascular cells of the arterial wall (31), and for mesenchymal
procursor cells to a site of osteoinduction (32), a subsequent
putative step in which these cells become condensed – a stage
preceding biomineralization, which is always associated with
an epithelium and an epithelial basement membrane in vivo –
may explain why hydroxyapatite mineralization occurs in the
Henle’s loop basement membrane. 
Finally, there is a third cell type that might hypothetically devel-
op Randall’s plaque. Given its particular conditions of low oxy-
gen tension, the papilla is a niche for stem cells (33), which
have been shown to differentiate into myofibroblasts and cells
expressing neuronal markers, and to spontaneously form cellu-
lar spheres. These renal stem cells can migrate to other parts
of the kidney, and to the medullary tubular epithelia in particu-
lar (33, 34). Since stem cells recovered from other tissues can
differentiate along the bone lineage, the third cell population
potentially capable of mineralizing in the kidney is that of the
papillary stem cells. 
Why the phenomenon occurs at papillary level might be be-
cause of the particular physiological conditions of the renal
papilla. We have already seen that oxygen tension is very low
at papillary level; indeed, ischemic lesions of the papilla in dia-
betic and analgesic-induced nephropathies are well known and
calcium deposits are so typical of the latter condition (with a
recorded 47% incidence of nephrocalcinosis [35]) that they are
used as a means for its CT diagnosis. Thus, in a subischemic
environment, the Henle’s loop cells or the pericytes, or the
stem cells might be very sensitive even to mild toxic insult, or
to high calcium, oxalate or phosphate concentrations. Cell dif-
ferentiation could occur as a consequence, leading to Randall’s
plaque formation. 
If this hypothesis is confirmed, it should open a new window on
renal lithiasis, possibly pointing towards new therapeutic ap-
proaches.
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